Feeds:
Posts
Comments

Posts Tagged ‘external beam radiotherapy’

JULY 27: URO TODAY: A combination approach to hormone and radiation treatment for men with localised but high risk prostate cancer works better than so-called mono-therapy, a new study has found. READ MORE>

Men treated with external beam radiotherapy and brachytherapy, short-course androgen suppression therapy with a luteinizing hormone-releasing hormone (LHRH) agonist plus an anti-androgen, have decreased prostate cancer-specific mortality compared with mono-therapy with an LHRH agonist, the researchers report.

NEW PROSTATE CANCER INFOLINK: Another study (of about 200 patients) in Japan found combined androgen blockade with an LHRH) agonist + bicalutamide 80 mg had a small, marginally significant overall survival benefit compared to an LHRH agonist + a placebo (ie, LHRH agonist monotherapy) at a median follow-up of 5.2 years. READ MORE>

Read Full Post »

JULY 15: NEW PROSTATE CANCER INFOLINK: Eight-year outcome data are now available for patients with Gleason score 8-10 prostate cancer treated with brachytherapy, external beam radiotherapy, and androgen deprivation therapy. The authors conclude that 8-year outcomes after this combination regimen show favourable biochemical and distant control, as well disease-specific survival rates for patients with Gleason scores of 8-10. READ MORE> and HERE>

Read Full Post »

JULY 5: NEW PROSTATE CANCER INFOLINK: It is clear from a new study that prostate cancer patients taking anticoagulant therapy, for whatever reason, have a significant risk of bleeding as an adverse effect associated with external beam radiotherapy. READ MORE>

Read Full Post »